Log in

NASDAQ:WVEWave Life Sciences Stock Price, Forecast & News

$8.78
-0.12 (-1.35 %)
(As of 07/28/2020)
Add
Compare
Today's Range
$8.72
Now: $8.78
$9.06
50-Day Range
$8.76
MA: $10.13
$11.23
52-Week Range
$6.61
Now: $8.78
$39.98
Volume324,507 shs
Average Volume308,873 shs
Market Capitalization$313.71 million
P/E RatioN/A
Dividend YieldN/A
Beta0.02
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It focuses on proprietary programs in neurology in the central nervous system and neuromuscular system. The company has a research, license, and option agreement with Pfizer Inc. and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of stereopure oligonucleotide therapeutics and oligonucleotide therapeutics. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.
Read More
Wave Life Sciences logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.73 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:WVE
CUSIPN/A
Phone65-6236-3388

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$15.98 million
Book Value$1.86 per share

Profitability

Net Income$-193,640,000.00
Net Margins-1,150.43%

Miscellaneous

Employees250
Market Cap$313.71 million
Next Earnings Date8/10/2020 (Confirmed)
OptionableOptionable
$8.78
-0.12 (-1.35 %)
(As of 07/28/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive WVE News and Ratings via Email

Sign-up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Wave Life Sciences (NASDAQ:WVE) Frequently Asked Questions

How has Wave Life Sciences' stock been impacted by COVID-19 (Coronavirus)?

Wave Life Sciences' stock was trading at $8.12 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, WVE stock has increased by 8.1% and is now trading at $8.78.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Wave Life Sciences?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Wave Life Sciences in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Wave Life Sciences
.

When is Wave Life Sciences' next earnings date?

Wave Life Sciences is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020.
View our earnings forecast for Wave Life Sciences
.

How can I listen to Wave Life Sciences' earnings call?

Wave Life Sciences will be holding an earnings conference call on Monday, August 10th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Wave Life Sciences' earnings last quarter?

Wave Life Sciences Ltd (NASDAQ:WVE) announced its earnings results on Monday, May, 11th. The company reported ($1.38) EPS for the quarter, missing the Zacks' consensus estimate of ($1.34) by $0.04. The company earned $4.16 million during the quarter, compared to analyst estimates of $7.26 million. Wave Life Sciences had a negative net margin of 1,150.43% and a negative return on equity of 219.06%.
View Wave Life Sciences' earnings history
.

What price target have analysts set for WVE?

6 brokerages have issued 1-year price targets for Wave Life Sciences' stock. Their forecasts range from $10.00 to $25.00. On average, they expect Wave Life Sciences' stock price to reach $19.20 in the next year. This suggests a possible upside of 118.7% from the stock's current price.
View analysts' price targets for Wave Life Sciences
.

Has Wave Life Sciences been receiving favorable news coverage?

Media headlines about WVE stock have been trending negative recently, InfoTrie reports. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Wave Life Sciences earned a media sentiment score of -2.2 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term.
View the latest news about Wave Life Sciences
.

Are investors shorting Wave Life Sciences?

Wave Life Sciences saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 5,010,000 shares, an increase of 6.8% from the June 15th total of 4,690,000 shares. Based on an average daily volume of 506,900 shares, the short-interest ratio is currently 9.9 days. Approximately 17.6% of the shares of the stock are short sold.
View Wave Life Sciences' Current Options Chain
.

Who are some of Wave Life Sciences' key competitors?

What other stocks do shareholders of Wave Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Wave Life Sciences investors own include Gilead Sciences (GILD), Crispr Therapeutics (CRSP), Exelixis (EXEL), Novavax (NVAX), Sangamo Therapeutics (SGMO), Sorrento Therapeutics (SRNE), Aduro BioTech (ADRO), Micron Technology (MU), AT&T (T) and TherapeuticsMD (TXMD).

Who are Wave Life Sciences' key executives?

Wave Life Sciences' management team includes the following people:
  • Dr. Paul B. Bolno, Pres, CEO & Director (Age 45)
  • Dr. Christopher Francis Ph.D., Sr. VP of Corp. Devel. & Head of Emerging Areas (Age 41)
  • Dr. Chandra Vargeese, Sr. VP of Drug Discovery (Age 58)
  • Dr. Takeshi Wada, Scientific Advisor (Age 57)
  • Mr. Keith C. Regnante, Chief Financial Officer (Age 49)

What is Wave Life Sciences' stock symbol?

Wave Life Sciences trades on the NASDAQ under the ticker symbol "WVE."

Who are Wave Life Sciences' major shareholders?

Wave Life Sciences' stock is owned by many different institutional and retail investors. Top institutional shareholders include Matisse Capital (0.12%), SG Americas Securities LLC (0.03%) and Assenagon Asset Management S.A. (0.03%). Company insiders that own Wave Life Sciences stock include Chandra Vargeese, Chris Francis, Gregory L Verdine, Keith Regnante, Michael A Panzara, Paul Bolno and Ra Capital Management, Llc.
View institutional ownership trends for Wave Life Sciences
.

Which major investors are selling Wave Life Sciences stock?

WVE stock was sold by a variety of institutional investors in the last quarter, including Matisse Capital. Company insiders that have sold Wave Life Sciences company stock in the last year include Chandra Vargeese, Gregory L Verdine, Michael A Panzara, and Paul Bolno.
View insider buying and selling activity for Wave Life Sciences
.

Which major investors are buying Wave Life Sciences stock?

WVE stock was purchased by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, and Assenagon Asset Management S.A..
View insider buying and selling activity for Wave Life Sciences
.

How do I buy shares of Wave Life Sciences?

Shares of WVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Wave Life Sciences' stock price today?

One share of WVE stock can currently be purchased for approximately $8.78.

How big of a company is Wave Life Sciences?

Wave Life Sciences has a market capitalization of $313.71 million and generates $15.98 million in revenue each year. The company earns $-193,640,000.00 in net income (profit) each year or ($5.72) on an earnings per share basis. Wave Life Sciences employs 250 workers across the globe.

What is Wave Life Sciences' official website?

The official website for Wave Life Sciences is www.wavelifesciences.com.

How can I contact Wave Life Sciences?

Wave Life Sciences' mailing address is 7 STRAITS VIEW #12-00 MARINA ONE EAST TOWER, SINGAPORE U0, 018936. The company can be reached via phone at 65-6236-3388 or via email at [email protected]

This page was last updated on 8/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.